Related Experiment Video

Updated: May 10, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

[Molecular bases of platinum-resistance in testicular cancer]

Josep Ramon Germà-Lluch1, Josep Maria Piulats

  • 1Instituto Catalán de Oncología de Hospitalet, IDIBELL, Hospitalet, Barcelona, España. jrgerma@iconcologia.net

Archivos Espanoles De Urologia
|June 25, 2013
PubMed

Insights

Cisplatin is a vital chemotherapy drug for testicular germ cell tumors, but resistance limits its effectiveness. This review explores the biological mechanisms of cisplatin resistance, focusing on testicular cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Cisplatin is a foundational chemotherapy agent for germ cell testicular tumors and other cancers.
  • Tumor resistance to cisplatin, both primary and acquired, poses a significant clinical challenge.
  • While effective, up to 20% of metastatic testicular germ cell tumor patients develop resistance, often secondary.

Purpose:

  • To review the biological mechanisms of cisplatin resistance.
  • To provide a global perspective on cisplatin resistance mechanisms.
  • To specifically focus on cisplatin resistance in testicular germ cell tumors.

Summary:

  • Cisplatin functions by binding to DNA, initiating DNA damage recognition and apoptosis via the mitochondrial pathway.
  • Resistance mechanisms are categorized into those occurring before DNA binding and those after DNA binding.
  • Research on resistance mechanisms has largely utilized ovarian and lung tumors as models.

Impact:

  • Understanding cisplatin resistance mechanisms is crucial for improving treatment strategies for testicular germ cell tumors.
  • This review aims to consolidate current knowledge and guide future research in overcoming cisplatin resistance.
  • Identifying specific resistance pathways in testicular cancers could lead to novel therapeutic interventions.

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...